- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 54.25M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 54.8M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 54.7M sh |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $4.3M |
| Dividends Paid restated | Q1 2026 · Mar 31, 2025 | $4.3M |
| Capex | Q1 2026 · Mar 31, 2026 | $27.8M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $40.6M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$122.6M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $66.2M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $396.3M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $409M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $57.2M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $60.9M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $361.5M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $535.5M |
| Cash And Equivalents restated | Q1 2026 · Mar 31, 2025 | $351.6M |
| Cash And Equivalents restated | Q1 2026 · Dec 31, 2024 | $455.8M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.68B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.68B |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $1.45B |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $1.41B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.67B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.85B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.53B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.73B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.14B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $2.33B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $4.21B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.41B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.32 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.81 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.32 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.82 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $105.8M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $99.5M |
| Net Income | Q1 2026 · Mar 31, 2026 | $17.4M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | $44.2M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $24.4M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $70.4M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $134.7M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $170.7M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.43B |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $1.48B |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.56B |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $1.65B |